The public isn’t wild for this tech theme yet, but it’s just a matter of time
This overlooked tech theme could be the next big winner. Plus, a bullish biotech breakout and key signals from AI and market trends.
Read this issue
Biotech
4 Articles
Why Trump wants this sector to soar
The past week has been generally unpleasant for most financial markets, but if you’re looking for some good news, look at the biotechnology sector.
It just passed an important “stress test,” which is bullish.
Read this issue
Danaher Makes a Splash – What Investors Should Know About the $9.9 Billion Acquisition of Masimo
Danaher is acquiring Masimo in a $9.9 billion all-cash deal. Here’s what the acquisition means for DHR stock, Masimo’s Apple litigation, and long-term investors.
Read this issue
Big news in the great “AI Boom or AI Bust” debate
Big news in the great “AI Boom or AI Bust” debate as semiconductor stocks hit new highs, reinforcing the strength of the AI bull case while weighing both sides of this critical market trend.
Read this issue